Choong ANG Vaccine Laboratory

중앙백신 · 072020

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$63.8M (₩88.1B)

Overview

Choong ANG Vaccine Laboratory makes vaccines and biological medicines that protect livestock and companion animals from infectious diseases.

Its products are used by livestock farmers and veterinary professionals across South Korea, and it is listed on KOSDAQ, Korea's small-cap and technology exchange. The company's core business is concentrated in biological preparations, vaccines in particular, rather than conventional antibiotic treatments, reflecting a broader industry shift from treating disease to preventing it.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$35.6M
▲ +7.6% YoY
Operating profit · FY2025
US$4.7M
▲ +12.5% YoY
Net income · FY2025
US$4.5M
▼ −10.1% YoY

Revenue

  • FY2023US$30.3M
  • FY2024US$33M
  • FY2025US$35.6M

Operating profit

  • FY2023US$5.1M
  • FY2024US$4.2M
  • FY2025US$4.7M

Net income

  • FY2023US$4.3M
  • FY2024US$5M
  • FY2025US$4.5M

Key ratios (FY2025)

ROE
5.8%
Debt/Eq
16.6%
Op. margin
13.2%
Net margin
12.6%
Rev. YoY
▲ +7.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.